Buhlak, S.; Abad, N.; Akachar, J.; Saffour, S.; Kesgun, Y.; Dik, S.; Yasin, B.; Bati-Ayaz, G.; Hanashalshahaby, E.; Türkez, H.;
et al. Design, Synthesis, and Computational Evaluation of 3,4-Dihydroquinolin-2(1H)-One Analogues as Potential VEGFR2 Inhibitors in Glioblastoma Multiforme. Pharmaceuticals 2025, 18, 233.
https://doi.org/10.3390/ph18020233
AMA Style
Buhlak S, Abad N, Akachar J, Saffour S, Kesgun Y, Dik S, Yasin B, Bati-Ayaz G, Hanashalshahaby E, Türkez H,
et al. Design, Synthesis, and Computational Evaluation of 3,4-Dihydroquinolin-2(1H)-One Analogues as Potential VEGFR2 Inhibitors in Glioblastoma Multiforme. Pharmaceuticals. 2025; 18(2):233.
https://doi.org/10.3390/ph18020233
Chicago/Turabian Style
Buhlak, Shafeek, Nadeem Abad, Jihane Akachar, Sana Saffour, Yunus Kesgun, Sevval Dik, Betul Yasin, Gizem Bati-Ayaz, Essam Hanashalshahaby, Hasan Türkez,
and et al. 2025. "Design, Synthesis, and Computational Evaluation of 3,4-Dihydroquinolin-2(1H)-One Analogues as Potential VEGFR2 Inhibitors in Glioblastoma Multiforme" Pharmaceuticals 18, no. 2: 233.
https://doi.org/10.3390/ph18020233
APA Style
Buhlak, S., Abad, N., Akachar, J., Saffour, S., Kesgun, Y., Dik, S., Yasin, B., Bati-Ayaz, G., Hanashalshahaby, E., Türkez, H., & Mardinoglu, A.
(2025). Design, Synthesis, and Computational Evaluation of 3,4-Dihydroquinolin-2(1H)-One Analogues as Potential VEGFR2 Inhibitors in Glioblastoma Multiforme. Pharmaceuticals, 18(2), 233.
https://doi.org/10.3390/ph18020233
